CD44 is involved in tumor angiogenesis; an activation antigen on human endothelial cells

Blood

Volumn 90, Issue 3, 1997, Pages 1150-1159

  Griffioen, Arjan W ^a   Coenen, Marieke J H ^b   Damen, Cora A ^b   Hellwig, Sandra M M ^b   Van Weering, David H J ^b   Vooys, Wim ^b   Blijham, Geert H ^b   Groenewegen, Gerard ^b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; HERMES ANTIGEN;

ANGIOGENESIS; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; TUMOR VASCULARIZATION;

EID: 0030789004     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.3.1150.1150_1150_1159     Document Type: Article

References (45)

1. Folkman J: What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82:4, 1990
2. Folkman J, Shing Y: Angiogenesis. J Biol Chem 267:10931, 1992
3. Schlingemann RO, Rietveld FJ, Kwaspen F, van de Kerkhof PC, de Waal RM, Ruiter DJ: Differential expression of markers for endothelial cells, pericytes, and basal lamina in the microvasculature of tumors and granulation tissue. Am J Pathol 138:1335, 1991
4. Renkonen R, Paavonen T, Nortamo P, Gahmberg CG: Expression of endothelial adhesion molecules in vivo. Increased endothelial ICAM-2 expression in lymphoid malignancies. Am J Pathol 140:763, 1992
5. Kuzu I, Bicknell R, Fletcher CD, Gatter KC: Expression of adhesion molecules on the endothelium of normal tissue vessels and vascular tumors. Lab Invest 69:322, 1993
6. Doussis Anagnostopoulou I, Kaklamanis L, Cordell J, Jones M, Turley H, Pulford K, Simmons D, Mason D, Gatter K: ICAM-3 expression on endothelium in lymphoid malignancy. Am J Pathol 143:1040, 1993
7. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B: CD44 is the principal cell surface receptor for hyaluronate. Cell 61:1303, 1990
8. Jalkanen ST, Bargatze RF, Herron LR, Butcher EC: A lymphoid cell surface glycoprotein involved in endothelial cell recognition and lymphocyte homing in man. Eur J Immunol 16:1195, 1986
9. Taher EI, Griffioen AW, Schilder-Tol EJM, Borst J, Pals ST: CD44 is involved in T lymphocyte activation. Association with lck tyrosin kinase. J Biol Chem 271:2863, 1996
10. Gunthert U, Hofmann M, Rudy W, Reber S, Zoller M, Haussmann I, Matzku S, Wenzel A, Ponta H, Herrlich P: A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65:13, 1991
11. Lesley J, Hyman R, Kincade PW: CD44 and its interaction with extracellular matrix. Adv Immunol 54:271, 1993
12. Alho AM, Underhill CB: The hyaluronate receptor is preferentially expressed on proliferating epithelial cells. J Cell Biol 108:1557, 1989
13. Picker LJ, Nakache M, Butcher EC: Monoclonal antibodies to human lymphocyte homing receptors define a novel class of adhesion molecules on diverse cell types. J Cell Biol 109:927, 1989
14. Mackay F, Loetscher H, Stueber D, Gehr G, Lesslauer W: Tumor necrosis factor alpha (TNF-alpha)-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-R55. J Exp Med 177:1277, 1993
15. Bennett KL, Jackson DG, Simon JC, Tanczos E, Peach R, Modrell B, Stamenkovic I, Plowman G, Aruffo A: CD44 isoforms containing exon V3 are responsible for the presentation of heparinbinding growth factor. J Cell Biol 128:687, 1995
16. Lesley J, Hyman R: CD44 can be activated to function as a hyaluronic acid receptor in normal murine T cells. Eur J Immunol 22:2719, 1992
17. Lesley J, He Q, Miyake K, Hamann A, Hyman R, Kincade PW: Requirements for hyaluronic acid binding by CD44: A role for the cytoplasmic domain and activation by antibody. J Exp Med 175:257, 1992
18. Bartolazzi A, Nocks A, Aruffo A, Spring F, Stamenkovic I: Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan. J Cell Biol 132:1199, 1996
19. Bennett KL, Modrell B, Greenfield B, Bartolazzi A, Stamenkovic I, Peach R, Jackson DG, Spring F, Aruffo A: Regulation of CD44 binding to hyaluronan by glycosylation of variably spliced exons. J Cell Biol 131:1623, 1995
20. DeGrendele HC, Estess P, Picker LJ, Siegelman MH: CD44 and its ligand hyaluronate mediate rolling under physiologic flow: A novel lymphocyte-endothelial cell primary adhesion pathway. J Exp Med 183:1119, 1996
21. Pals ST, Hogervorst F, Keizer GD, Thepen T, Horst E, Figdor CC: Identification of a widely distributed 90-kDa glycoprotein that is homologous to the Hermes-1 human lymphocyte homing receptor. J Immunol 143:851, 1989
22. Kansas GS, Wood GS, Dailey MO: A family of cell-surface glycoproteins defined by a putative anti-endothelial cell receptor antibody in man. J Immunol 142:3050, 1989
23. Jalkanen S, Bargatze RF, de los Toyos J, Butcher EC: Lymphocyte recognition of high endothelium: Antibodies to distinct epitopes of an 85-95-kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells. J Cell Biol 105:983, 1987
24. Groenewegen G, De Leij M, Jeunhomme GMAA, Buurman WA: Supernatants of human leukocytes contain mediators, different from interferon-gamma, which induces expression of MHC class II antigens. J Exp Med 164:131, 1986
25. Griffioen AW, Damen CA, Martinotti S, Blijham GH, Groenewegen G: Endothelial ICAM-1 expression is suppressed in human malignancies; role of angiogenic factors. Cancer Res 56:1111, 1996
26. Griffioen AW, Damen CA, Blijham GH, Groenewegen G: Tumor angiogenesis is accompanied by a decreased inflammatory response of tumor associated endothelium. Blood 88:667, 1996
27. Netland PA, Zetter B, Via DP, Voyta JC: In situ labeling of vascular endothelium with fluorescent acetylated low density lipoprotein. Histochem J 17:1309, 1985
28. Grantzer HG: Monoclonal antibody to 5-bromo- and 5-iodo-deoxyuridine: A new reagent for detection of DNA replication. Science 218:474, 1982
29. van Weering DH, Baas PD, Bos JL: A PCR-based method for the analysis of human CD44 splice products. PCR Methods Appl 3:100, 1993
30. Hellwig SMM, Damen CA, Groenewegen G, Blijham GH, Griffioen AW: Endothelial CD34 is suppressed in human malignancies; role of angiogenic factors. Cancer Lett (in press)
31. Horst E, Meijer CJ, Radaskiewicz T, van Dongen JJ, Pieters R, Figdor CG, Hooftman A, Pals ST: Expression of a human homing receptor (CD44) in lymphoid malignancies and related stages of lymphoid development. Leukemia 4:383, 1990
32. Burrows FJ, Thorpe PE: Eradication of large solid tumors in mice with an immunotoxin directed against tumor vasculature. Proc Natl Acad Sci USA 90:8996, 1993
33. Till M, Ray RD, Uhr JW, Thorpe PE, Vitetta ES: An assay that predicts the ability of monoclonal antibodies to form potent ricin A chain-containing immunotoxins. Cancer Res 48:1119, 1996
34. Dinota A, Tazzari PL, Michieli M, Visani G, Gobbi M, Bontadini A, Tassi C, Fanin R, Damiani D, Grandi M, Piled S, Bolognesi A, Stirpe F, Baccarani M, Tsuruo T, Tura S: In vitro bone marrow purging of multidrug-resistant cells with a mouse monoclonal antibody directed against Mr 170,000 glycoprotein and a saporin-conjugated ami-mouse antibody. Cancer Res 50:4291, 1990
35. Griffioen AW, Horst E, Heider KH, Wielenga VJM, Adolf GR, Herrlich P, Pals ST: Expression of CD44 splice variants during lymphocyte activation and tumor progression. Cell Adhes Commun 2:1, 1994
36. Lesley J, English N, Perschl A, Gregoroff J, Hyman R: Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation. J Exp Med 182:431, 1995
37. Katoh S, Zheng Z, Oritani K, Shimozato T, Kincade PW: Glycosylation of CD44 negatively regulates its recognition of hyaluronan. J Exp Med 182:419, 1995
38. Schadendorf D, Heidel J, Gawlik C, Suter C, Czarnetzki BM: Association with clinical outcome of expression of VLA-4 in primary cutaneous malignant melanoma as well as P-selectin and E-selectin in intratumoral vessels. J Natl Cancer Inst 87:366, 1995
39. Trochon V, Mabilat C, Bertrand P, Legrand Y, Smadja-Joffe F, Soria C, Delpech B, Lu H: Evidence of involvement of CD44 in endothelial cell proliferation, migration and angiogenesis in vitro. Int J Cancer 66:664, 1996
40. Gustafson S, Bjorkman T, Forsbery N, Lind T, Wikstrom T, Lidholt K: Accessible hyaluronan receptors identical to ICAM-1 in mouse mast-cell tumors. Glycoconj J 12:350, 1995
41. Denning SM, Le PT, Singer KH, Haynes BF: Antibodies against the CD44 p80, lymphocyte homing receptor molecule augment human peripheral blood T cell activation. J Immunol 144:7, 1990
42. Koopman G, van Kooyk Y, de Graaff M, Meyer CJ, Figdor CG, Pals ST: Triggering of the CD44 antigen on T lymphocytes promotes T cell adhesion through the LFA-1 pathway. J Immunol 145:3589, 1990
43. Koopman G, Heider KH, Horst E, Adolf GR, van den Berg F, Ponta H, Herrlich P, Pals ST: Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44. J Exp Med 177:897, 1993
44. Hofmann M, Rudy W, Zoller M, Tolg C, Ponta H, Herrlich P, Gunthert U: CD44 splice variants confer metastatic behavior in rats: Homologous sequences are expressed in human tumor cell lines. Cancer Res 51:5292, 1991
45. Thorpe PE, Burrows FJ: Antibody-directed targeting of the vasculature of solid tumors. Breast Cancer Res Treat 36:237, 1995